Winnergy Medical PCL (BKK:WINMED)
Thailand · Delayed Price · Currency is THB 1.150
-0.020 (-1.71%)
Sep 3, 2026, 4:22 PM ICT
Winnergy Medical PCL Ratios and Metrics
Market cap in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 460 | 396 | 724 | 1,184 | 1,704 | 2,360 | |
Market Cap Growth | -15.44% | -45.30% | -38.85% | -30.52% | -27.80% | - |
Enterprise Value | 831 | 771 | 888 | 1,337 | 1,804 | 2,287 |
Last Close Price | 1.15 | 0.98 | 1.75 | 2.83 | 4.02 | 5.50 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 27.40 | 26.10 | 24.74 | 38.64 | 28.09 | 36.19 |
PS Ratio | 0.66 | 0.61 | 1.11 | 1.85 | 2.42 | 4.38 |
PB Ratio | 0.72 | 0.62 | 1.15 | 1.96 | 2.86 | 4.13 |
P/TBV Ratio | 0.77 | 0.66 | 1.21 | 2.04 | 2.94 | 4.22 |
P/OCF Ratio | 5.25 | - | 6.52 | 31.59 | - | 32.10 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.19 | 1.19 | 1.36 | 2.09 | 2.57 | 4.25 |
EV/EBITDA Ratio | 14.83 | 14.71 | 13.07 | 17.66 | 19.37 | 27.73 |
EV/EBIT Ratio | 80.20 | 91.76 | 36.29 | 36.07 | 31.01 | 40.09 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.60 | 0.57 | 0.49 | 0.42 | 0.29 | 0.11 |
Debt / EBITDA Ratio | 6.80 | 6.38 | 4.13 | 3.13 | 1.73 | 0.70 |
Net Debt / Equity Ratio | 0.58 | 0.54 | 0.45 | 0.37 | 0.17 | -0.11 |
Net Debt / EBITDA Ratio | 7.28 | 6.56 | 4.19 | 2.93 | 1.07 | -0.76 |
Net Debt / FCF Ratio | 8.12 | -7.84 | -4.22 | -4.80 | -0.75 | 1.29 |
Asset Turnover | 0.60 | 0.58 | 0.63 | 0.70 | 0.88 | 0.86 |
Inventory Turnover | 2.26 | 2.35 | 3.24 | 3.62 | 5.16 | 4.16 |
Quick Ratio | 1.15 | 1.06 | 1.30 | 1.35 | 1.94 | 2.55 |
Current Ratio | 1.69 | 1.75 | 1.83 | 1.88 | 2.53 | 3.23 |
Return on Equity (ROE) | 2.64% | 2.39% | 4.73% | 5.11% | 10.40% | 17.14% |
Return on Assets (ROA) | 0.56% | 0.47% | 1.47% | 2.54% | 4.54% | 5.71% |
Return on Invested Capital (ROIC) | 0.77% | 0.70% | 2.42% | 4.24% | 8.44% | 11.39% |
Return on Capital Employed (ROCE) | 1.30% | 1.10% | 3.00% | 5.30% | 8.60% | 9.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.65% | 3.83% | 4.04% | 2.59% | 3.56% | 2.76% |
FCF Yield | 9.94% | -11.06% | -9.30% | -3.89% | -7.73% | -2.06% |
Dividend Yield | 1.23% | 1.28% | 1.41% | 1.04% | 1.41% | 1.18% |
Payout Ratio | 29.78% | 65.25% | 40.33% | 74.28% | 42.85% | 63.94% |
Buyback Yield / Dilution | - | - | - | - | -11.55% | -119.55% |
Total Shareholder Return | 1.23% | 1.28% | 1.41% | 1.04% | -10.14% | -118.37% |